Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Mesa Biotech Gets FDA Clearance, CLIA Waiver for Flu A/B Test, POC System

Mesa Biotech Gets FDA Clearance, CLIA Waiver for Flu A/B Test, POC System

Feb 07, 2018

NEW YORK (GenomeWeb) – Mesa Biotech announced today it has received 510(k) clearance and CLIA waiver from the US Food and Drug Administration for a test to detect and distinguish influenza A and B from nasal swab specimens. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. 

What's Popular?

In PCR

  1. CDC Study Finds Abbott BinaxNow SARS-CoV-2 Antigen Test Less Sensitive Than PCR, But Still Useful

  2. Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

  3. Lucira Health Files for $115M IPO

  4. Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

  5. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.